Form 4: Arteris Director Claudia Munce Granted Over 20,000 Restricted Stock Units

Arteris, Inc. Director Claudia F. Munce was granted 20,839 restricted stock units (RSUs) on June 3, 2025, increasing her direct beneficial ownership to 100,851 shares.

Summary

• Claudia F. Munce, a Director of Arteris, Inc. (AIP), acquired 20,839 shares of common stock on June 3, 2025.
• The acquisition was in the form of Restricted Stock Units (RSUs) with a transaction price of $0.00 per unit.
• Following this transaction, Ms. Munce's direct beneficial ownership of Arteris, Inc. common stock increased to 100,851 shares.
• Each RSU represents a contingent right to receive one share of the Issuer's common stock.
• The RSUs are scheduled to vest in full on the earlier of (i) the first anniversary of the grant date (June 3, 2026) or (ii) immediately before the annual meeting of the Issuer's stockholders following the grant date, contingent on Ms. Munce's continued service to the Board.

Sentiment

Score: 6

Explanation: The sentiment is slightly positive. While a Form 4 is primarily a disclosure of an insider transaction, the grant of RSUs to a director is a standard compensation practice that aligns director interests with shareholders, which is generally viewed favorably. It does not indicate any negative operational or financial news.

Positives

• The grant of Restricted Stock Units (RSUs) to a director aligns their interests with those of shareholders, as the value of the compensation is tied to the company's stock performance.
• An increase in insider ownership, even through grants, can signal confidence in the company's future prospects.

Future Outlook

The 20,839 Restricted Stock Units granted to Director Claudia F. Munce are expected to vest in full on the earlier of June 3, 2026, or immediately prior to the company's annual meeting of stockholders following the grant date, subject to her continued service.

Industry Context

The granting of Restricted Stock Units (RSUs) to non-employee directors is a common practice in the technology and semiconductor intellectual property (IP) industry, as well as across publicly traded companies, to attract and retain qualified board members and align their long-term interests with shareholder value.

Comparison to Industry Standards

• The use of RSUs as a component of director compensation is a standard practice across many industries, including technology, aligning director incentives with long-term shareholder value creation.
• The vesting schedule, tied to continued service and a one-year anniversary or next annual meeting, is typical for director equity grants, similar to practices observed at comparable companies in the semiconductor IP and software sectors like Synopsys (SNPS) or Cadence Design Systems (CDNS).

Corporate Governance

Related Party Transactions

• The grant of Restricted Stock Units (RSUs) to Claudia F. Munce, a director of Arteris, Inc., constitutes a related party transaction as it involves compensation provided by the company to a member of its board of directors.

Stakeholder Impact

• Shareholders: The RSU grant aligns the director's incentives with shareholder interests, as the value of the compensation is directly tied to the company's stock performance.
• Employees: No direct impact on general employees is indicated by this specific filing.

Next Steps

• The vesting of the 20,839 Restricted Stock Units (RSUs) on the earlier of June 3, 2026, or immediately before the annual meeting of stockholders following the grant date.

Key Dates

Keywords

Arteris Inc., AIP, SEC Form 4, Insider Trading, Restricted Stock Units, RSU Grant, Director Compensation, Beneficial Ownership, Corporate Governance